Cargando…

Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells

Triple-negative breast cancer (TNBC) is a subtype of breast cancer lacking targeted therapy currently. Recent studies imply that protein kinase C may play important roles in TNBC development and could be a specific target. In this study, we evaluated the anti-proliferative activity of PKC inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Wanjun, Huang, Jiajun, Yuan, Zhongwen, Feng, Senling, Xie, Ying, Ma, Wenzhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435721/ https://www.ncbi.nlm.nih.gov/pubmed/28515445 http://dx.doi.org/10.1038/s41598-017-02222-0

Ejemplares similares

In Vitro Anticancer Activity of a Nonpolar Fraction from Gynostemma pentaphyllum (Thunb.) Makino
por: Li, Yantao, et al.
Publicado: (2016)

Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells
por: Ma, Wenzhe, et al.
Publicado: (2015)

The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis
por: Ghashghaeinia, Mehrdad, et al.
Publicado: (2020)

Natural Protein Kinase Inhibitors, Staurosporine, and Chelerythrine Suppress Wheat Blast Disease Caused by Magnaporthe oryzae Triticum
por: Chakraborty, Moutoshi, et al.
Publicado: (2022)

APTM, a Thiophene Heterocyclic Compound, Inhibits Human Colon Cancer HCT116 Cell Proliferation Through p53-Dependent Induction of Apoptosis
por: Liao, Xiaolin, et al.
Publicado: (2018)

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
por: He, Jichao, et al.
Publicado: (2019)

Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis
por: Mullen, McKay, et al.
Publicado: (2021)

Chelerythrine Chloride: A Potential Rumen Microbial Urease Inhibitor Screened by Targeting UreG
por: Zhang, Xiaoyin, et al.
Publicado: (2021)

Recognition of Chelerythrine to Human Telomeric DNA and RNA G-quadruplexes
por: Bai, Li-Ping, et al.
Publicado: (2014)

Extraction of Chelerythrine and its Effects on Pathogenic Fungus Spore Germination
por: Wei, Qinghui, et al.
Publicado: (2017)

Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine
por: Chen, Nianzhi, et al.
Publicado: (2022)

Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family
por: Kawai, Masaaki, et al.
Publicado: (2015)

c‐Src inhibitor selectively inhibits triple‐negative breast cancer overexpressed Vimentin in vitro and in vivo
por: Lou, Longquan, et al.
Publicado: (2018)

Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells
por: O’Grady, Shane, et al.
Publicado: (2022)

Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells
por: Zhao, Zhijing, et al.
Publicado: (2018)

In Vitro Antifungal Activity of Sanguinarine and Chelerythrine Derivatives against Phytopathogenic Fungi
por: Yang, Xin-Juan, et al.
Publicado: (2012)

Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling
por: Shahi Thakuri, Pradip, et al.
Publicado: (2020)

Selective targeting of PPARγ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency
por: Zheng, Weili, et al.
Publicado: (2015)

Overexpression of β-Arrestins inhibits proliferation and motility in triple negative breast cancer cells
por: Bostanabad, Saber Yari, et al.
Publicado: (2021)

Gonadotropin-releasing hormone receptor inhibits triple-negative breast cancer proliferation and metastasis
por: Chen, Cai-Ping, et al.
Publicado: (2022)

Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells
por: Yi, Yong Weon, et al.
Publicado: (2013)

Norepinephrine/β(2)-Adrenergic Receptor Pathway Promotes the Cell Proliferation and Nerve Growth Factor Production in Triple-Negative Breast Cancer
por: Jin, Meihua, et al.
Publicado: (2023)

Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer
por: Cuenca-López, María Dolores, et al.
Publicado: (2015)

Chelerythrine Chloride Downregulates β-Catenin and Inhibits Stem Cell Properties of Non-Small Cell Lung Carcinoma
por: Heng, Win Sen, et al.
Publicado: (2020)

Synergistic Activity of Econazole-Nitrate and Chelerythrine against Clinical Isolates of Candida albicans
por: Chen, Zhibao, et al.
Publicado: (2014)

Antibacterial mechanism of chelerythrine isolated from root of Toddalia asiatica (Linn) Lam
por: He, Nan, et al.
Publicado: (2018)

Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19
por: Valipour, Mehdi, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine –possible therapeutic implication
por: Ghashghaeinia, Mehrdad, et al.
Publicado: (2020)

Using Liposomes to Alleviate the Toxicity of Chelerythrine, a Natural PKC Inhibitor, in Treating Non-Small Cell Lung Cancer
por: Wang, Jiahui, et al.
Publicado: (2021)

Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer
por: Zhu, Ying, et al.
Publicado: (2023)

ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer
por: Reese, Jordan M., et al.
Publicado: (2017)

Azurocidin 1 inhibits the aberrant proliferation of triple‑negative breast cancer through the regulation of pyroptosis
por: Lei, Shanshan, et al.
Publicado: (2023)

Anti-cancer effects of Gynostemma pentaphyllum (Thunb.) Makino (Jiaogulan)
por: Li, Yantao, et al.
Publicado: (2016)

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
por: Li, Mengxing, et al.
Publicado: (2021)

Chelerythrine Inhibits Stemness of Cancer Stem-Like Cells of Osteosarcoma and PI3K/AKT/mTOR Signal
por: Chen, Zhixing, et al.
Publicado: (2022)

Role of BET Inhibitors in Triple Negative Breast Cancers
por: Khandekar, Durga, et al.
Publicado: (2020)

HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
por: Maccallini, Cristina, et al.
Publicado: (2022)

TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole
por: Oberstadt, Moritz, et al.
Publicado: (2018)

Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Triple-Negative Breast Cancer
por: Peng, Peng, et al.
Publicado: (2023)

CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
por: Xiao, Weikai, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fu2969aungiukdce4vfglilioe